Profile data is unavailable for this security.
About the company
PRF Technologies Ltd is an Israel-based company engaged primarily in pharmaceutical sector. The Company is a producer of speciality pharmaceuticals as well as energy analytics powered by artificial intelligence (AI). The Firm develops reformulated and sustained‑release drug‑delivery platforms that combine proven generic medicines with proprietary extended‑release systems to improve patient outcomes. One of the Company's products is PRF‑110 - a ropivacaine‑based formulation designed to deliver localised, extended postoperative analgesia. The Company also advances OcuRingTD, a bio‑erodible drug‑release ring integrated with intraocular lenses for continuous delivery of medications in cataract surgery.In the energy analytics sector the Company operates DeepSolar platform that provides AI‑powered monitoring, forecasting, and optimisation tools for solar asset performance.
- Revenue in USD (TTM)0.00
- Net income in USD-4.09m
- Incorporated2007
- Employees2.00
- LocationPRF Technologies Ltd65 Yigal Alon St.TEL AVIV-YAFO 6744316IsraelISR
- Phone+972 37177051
- Fax+972 99542266
- Websitehttps://prf-tech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evofem Biosciences Inc | 17.73m | -5.56m | 1.17m | 32.00 | -- | -- | -- | 0.0658 | -0.058 | -0.058 | 0.0111 | -0.5661 | 0.9392 | 2.25 | 3.61 | 553,937.50 | -28.79 | -177.41 | -- | -- | 80.05 | 69.60 | -30.66 | -602.27 | 0.0797 | -0.2439 | -- | -- | 6.28 | -- | -117.93 | -- | -38.87 | -- |
| Procyon Corp | 4.98m | -312.97k | 1.53m | 19.00 | -- | 0.7027 | -- | 0.307 | -0.0387 | -0.0387 | 0.6138 | 0.2817 | 1.47 | 2.32 | 9.90 | 262,338.40 | -10.08 | 1.19 | -12.70 | 1.44 | 78.07 | 74.40 | -6.84 | 0.8691 | 2.41 | -- | 0.00 | -- | 6.35 | 3.53 | -367.38 | -- | 17.32 | -- |
| Universe Pharmaceuticals Inc | 17.86m | -3.67m | 1.53m | 216.00 | -- | 0.0273 | -- | 0.0858 | -10.13 | -10.13 | 39.18 | 99.64 | 0.2602 | 5.88 | 1.38 | 82,679.35 | -5.35 | -5.40 | -7.08 | -7.09 | 35.28 | 43.33 | -20.56 | -9.65 | 3.90 | -17.46 | 0.1416 | -- | -22.44 | -10.27 | 57.92 | -- | 46.30 | -- |
| Stemcell Holdings Inc | 9.98m | 3.10m | 1.64m | -- | -- | -- | 0.5008 | 0.1645 | 0.00008 | 0.00008 | 0.0003 | 0.0002 | 1.12 | -- | 5.20 | -- | 34.90 | -- | 68.19 | -- | 77.19 | -- | 31.04 | -- | -- | -- | 0.00 | -- | 85.10 | -- | 71.82 | -- | -- | -- |
| Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 1.73m | 40.00 | -- | -- | -- | 0.6255 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 2.58 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
| InVitro International | 716.89k | 6.22k | 1.83m | 16.00 | 235.00 | 2.56 | -- | 2.55 | 0.0004 | 0.0004 | 0.0402 | 0.0321 | 1.15 | -- | -- | -- | 0.995 | 7.89 | 1.09 | 8.83 | -- | -- | 0.8676 | 5.90 | -- | -- | -- | -- | -5.11 | 1.33 | -87.77 | -16.14 | -- | -- |
| PRF Technologies Ltd | 0.00 | -4.09m | 2.33m | 2.00 | 0.0099 | 0.1416 | -- | -- | 301.27 | 301.27 | 0.00 | 20.97 | 0.00 | -- | -- | 0.00 | -57.27 | -71.03 | -118.06 | -84.02 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -56.12 | -- | -- | -- |
| Scisparc Ltd | -100.00bn | -100.00bn | 2.41m | 2.00 | -- | -- | -- | -- | -- | -- | -- | -1.46 | -- | -- | -- | -- | -- | -63.15 | -- | -90.87 | -- | -- | -- | -456.81 | 0.5151 | -- | 1.04 | -- | -54.64 | -- | -22.69 | -- | -- | -- |
| LakeShore Biopharma Co Ltd | 89.67m | -14.58m | 2.65m | 573.00 | -- | 0.0184 | 0.3958 | 0.0296 | -0.7545 | -0.7545 | 4.68 | 3.51 | 0.427 | 0.5001 | 1.30 | 156,495.60 | -6.94 | -- | -15.95 | -- | 82.47 | -- | -16.26 | -- | 0.7452 | -2.63 | 0.453 | -- | 7.24 | -- | 76.93 | -- | -- | -- |
| SOHM Inc | -100.00bn | -100.00bn | 2.71m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| China Pharma Holdings Inc | 4.05m | -3.19m | 2.88m | 224.00 | -- | 0.3461 | -- | 0.7101 | -1.10 | -1.10 | 1.28 | 1.66 | 0.2769 | 2.17 | 14.52 | 18,090.54 | -21.80 | -18.69 | -35.67 | -37.95 | -10.94 | -1.14 | -78.72 | -44.96 | 0.1026 | -30.50 | 0.2884 | -- | -35.41 | -16.15 | -53.84 | -- | 16.49 | -- |
| CYANOTECH CORP | 25.27m | -1.78m | 2.96m | 83.00 | -- | 0.3666 | 15.64 | 0.117 | -0.2469 | -0.2469 | 3.51 | 1.09 | 1.05 | 2.21 | 12.81 | 304,433.80 | -7.41 | -6.08 | -13.42 | -8.05 | 32.00 | 32.26 | -7.03 | -6.37 | 0.2988 | -1.47 | 0.5089 | -- | 4.96 | -5.36 | 39.19 | -- | 1.97 | -- |
| Bio Essence Corp | 565.67k | -160.45k | 3.42m | 2.00 | -- | -- | -- | 6.05 | -0.0042 | -0.0042 | 0.0149 | -0.0816 | 1.26 | -- | 16.06 | 282,835.00 | -35.64 | -40.94 | -- | -- | 69.28 | 38.36 | -28.36 | -134.00 | -- | -57.42 | -- | -- | -- | -17.08 | -286.98 | -- | -- | -- |
Data as of Mar 02 2026. Currency figures normalised to PRF Technologies Ltd's reporting currency: US Dollar USD
3.23%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Morgan Stanley & Co. LLCas of 31 Dec 2025 | 25.60k | 1.27% |
| Two Sigma Securities LLCas of 31 Dec 2025 | 21.34k | 1.06% |
| XTX Markets LLCas of 31 Dec 2025 | 13.46k | 0.67% |
| UBS Securities LLCas of 31 Dec 2025 | 4.34k | 0.22% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2025 | 193.00 | 0.01% |
| SBI Securities Co., Ltd.as of 31 Dec 2025 | 6.00 | 0.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
